Clinical Trial Update: Methotrexate in Metastatic Colorectal Cancer With MSH2 Deficiency [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating methotrexate in advanced/metastatic colorectal cancer with MSH2 deficiency has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Advanced Colorectal Cancer | Phase 2 | Status: TERMINATED